Page 49 - Vaccination

People who are infected should also take vaccine: Bharat Biotech Chairman

People who are infected should also take a vaccine,and India is well prepared regarding the logistics for the vaccine distribution,Bharat BiotechChairman & MD Krishna Ella said on Wednesday. He was speaking in a virtual session on 'Sero surveillance significance in immunogenicity and safety in pre and post vaccination era' organised by industrybody CII. For the peoplewho are infected,shouldthey take a vaccine, "the answeris yes", becausethey may not have a goodT cells response..., Ella said. Talking about the company's efficacy trials of its COVID-19 vaccine, he said that for the efficacy trials the company has taken 24 centres all over the country so that it has tier I ,tierIIand tier III cities to capture the efficacy in a better way. On the distribution of vaccines in India, he said India is well prepared for that and Indian immunisation system is very robust, Ella said. Speaking at the session, Biocon ChairpersonKiran Mazumdar Shaw said, "We have to ensure we have a sense of .

What we know about the new coronavirus strain discovered in the UK

The new variant of the virus is capable of spreading faster and more easily.

Centre may not procure Pfizer-BioNTech Covid vaccine over high cost

At $37 per dose, the Pfizer vaccine is much more expensive compared to $3 per dose for the Covishield

Review panel asks vaccine makers to submit more data to get authorisation

Experts ask Bharat Biotech for phase 3 data, Serum's UK approval status

UK approves Pfizer, becomes the first country to roll out Covid-19 vaccine

With 800,000 doses expected to be delivered over the next few days, inoculations will begin next week

Moderna vaccine 100% effective in severe cases; to seek US, EU approval

The primary analysis, which included 196 cases, found the vaccine was 94.1 per cent effective, in line with preliminary findings released earlier this month.

Govt begins micro-planning for administering Covid-19 vaccine to the masses

Centre has asked states to update databases, train manpower, indicate resource requirements

Why a vaccine that stops coronavirus won't be enough to end the pandemic

A vaccine's ability to forestall a disease is also how vaccine developers typically design - and how regulators typically evaluate - Phase 3 clinical trials for vaccine candidates

Covid-19 pandemic led to revival of technology, expertise: Nandan Nilekani

He said that during Covid-19 crisis, digital and medical technologies stood out, which enabled people to work from home, and helped in dealing with the virus by developing better tests, drugs, vaccin

India to launch Covid-19 vaccine by August 15: ICMR chief Bhargava

ICMR and Hyderabad-based Bharat Biotech are jointly working on preclinical as well as clinical development of Covaxin

Covid-19 vaccine trials showing positive results: China's Sinovac Biotech

Sinovac is collaborating with Instituto Butantan in Brazil to prepare and conduct a phase III clinical study.

Roche mixes Actemra with Gilead's remdesivir in Covid-19 trial

Actemra and remdesivir are being used separately in some settings and clinical trials

CordenPharma extends Moderna deal to supply lipids to produce Covid vaccine

The expanded agreement will be effective immediately to help meet Moderna's increasing demand over the coming months

Glenmark to begin clinical trial in India to test Covid-19 drug combination

Drugmakers across the world have been rushing to develop a treatment or vaccine for the fast-spreading coronavirus, which has infected 5.5 million people globally, killing more than 345,000

How Singapore, India are contributing to a coronavirus vaccine race

Singapore has started to re-open some but limited businesses and social activities ahead of the official "circuit breaker" end date of June 1

China's Covid-19 vaccine shows promising results in early trials: Report

The trial was conducted by researchers at several laboratories and included 108 participants aged 18-60

Moderna's Covid-19 vaccine, first to be tested in US, appears safe: Study

The Moderna vaccine is one of more than 100 under development intended to protect against the novel coronavirus that has infected more than 4.7 million people globally

Chinese hackers trying to steal US' vaccine research on Covid-19: Reports

The hackers are also targeting information and intellectual property on treatments and testing for Covid-19, the report says

What is the second wave of Covid-19 and why should we be worried?

The disease could come back with a greater bang once the lockdown is lifted, with many of the infected being asymptomatic

Covid-19 vaccine: Oxford University to start human trials from today

The vaccine will be tested on around 500 volunteers and will focus on safety and tolerability, as well as providing an initial assessment of how effective the shot is